[글로벌리포트]Spain resumes vaccination against AstraZeneca … Extension of vaccination target

[앵커]

Vaccines for AstraZeneca, which were temporarily suspended in most of Europe, are being resumed one after another.

This is because the European Union Agency for Medicines said there is no risk of blood clots from the AstraZeneca vaccine.

Spain, hard hit by the coronavirus, has raised the upper limit on vaccinations against AstraZeneca from 55 to 65 as it rushed to resume vaccinations immediately.

Reporter Seong-Hwan Kim will comply.

[기자]

In Spain, where the number of new cases per day is thousands per day, the vaccination rate in Spain is 12%, similar to that of Germany and France.

Almost 6 million people have been vaccinated at least once, of which more than 1.8 million people have been vaccinated both times.

The AstraZeneca vaccine was recently resumed after the lump sum vaccination was stopped due to fear of blood clots, but the anxiety was not completely alleviated.

[오데 잘라케 / 스페인 마드리드 : 그렇게 안심할 수가 없어요. 그것이 진실입니다.]

The EU Drug Administration has announced that there is no link between the AstraZeneca vaccine and the formation of blood clots, but added that the rare phenomenon requires further analysis.

[김남경 / 스페인 마드리드·의사 : 제가 보기에는 바른 정보를 제공하기 위해 잠시 접종을 멈춘 것은 바르고 신중한 결정이라 생각됩니다.]

Spain, which has resumed vaccination, is accelerating vaccination by increasing the age of AstraZeneca from 18 to 55 to 65 years.

The policy is to obtain Pfizer, Moder, or Vaccine if you are 65 or older with an underlying medical condition.

[카롤리나 다리아스 / 보건부 장관 : 아스트라제네카 백신을 접종하고 55세 제한 나이를 없애고 65세로 연장합니다. (관련 보고서가) 좋아 보이지만 연구해야 하고 백신 사용 가능성을 지켜봐야 합니다.] [마르가란테로 / 스페인 마드리드 : 아스트라제네카 백신을 다시 접종할 수 있다는 것은 대단한 일이고 그것이 초래하는 모든 것은 (바이러스가 주는) 어떤 위험보다도 낫다고 생각합니다.] [앙헬라 도밍게스 / 바르셀로나 의과 대학 공중보건 예방의학과 교수 : 지금까지 AZ 혈전 반응은) 2백만 회 접종 중 한 명이었어요. 이것은 아주 적은 경우입니다. 백신 접종은 모든 시민이 연령이나 특징에 따라 모두 접종을 해야 훨씬 높은 효과를 거둘 수 있습니다.]

Despite the conclusion of the European Medicines Agency that vaccination has more benefits, Sweden and Norway will resume vaccination after self-investigation.

Although the safety of AstraZeneca was recently reconfirmed through a study in a phase 3 clinical trial that showed that the preventive effect of AstraZeneca was 79% in the United States, it will take longer to overcome the mistrust that still remains and increase the rate. vaccination.

I’m Seonghwan Kim from YTN World in Madrid, Spain.

# Spain # AstraZeneca Vaccine # Vaccination # European Drug Administration # Extended age limit # Crown 19 # Resume European vaccination

[저작권자(c) YTN & YTN plus 무단전재 및 재배포 금지]